ArticleNeuro-oncology advances

An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery-the BUMPER study.

Teresa Amaral et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.